YTHDF2 is significantly overexpressed in hepatoblastoma and HCC when compared with their adjacent non-cancerous tissues, and overexpression of YTHDF2 is closely connected with poor prognostic clinical outcomes (Cui et al., 2020; Shao et al., 2020). This evidence concerns the gene YTHDF2 and hepatocellular carcinoma.